White MA - Search Results

1

TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.

Cooper JM, Ou YH, McMillan EA, Vaden RM, Zaman A, Bodemann BO, Makkar G, Posner BA, White MA. Cooper JM, et al. Among authors: white ma. Cancer Res. 2017 Sep 15;77(18):5077-5094. doi: 10.1158/0008-5472.CAN-17-0829. Epub 2017 Jul 17. Cancer Res. 2017. PMID: 28716898 Free PMC article.

2

Ras GTPases: codon bias holds KRas down but not out.

Bodemann BO, White MA. Bodemann BO, et al. Among authors: white ma. Curr Biol. 2013 Jan 7;23(1):R17-20. doi: 10.1016/j.cub.2012.11.054. Curr Biol. 2013. PMID: 23305663 Free article.

3

Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling.

Borkowski R, Du L, Zhao Z, McMillan E, Kosti A, Yang CR, Suraokar M, Wistuba II, Gazdar AF, Minna JD, White MA, Pertsemlidis A. Borkowski R, et al. Among authors: white ma. Cancer Res. 2015 Feb 15;75(4):666-75. doi: 10.1158/0008-5472.CAN-14-1329. Epub 2014 Dec 17. Cancer Res. 2015. PMID: 25519225 Free PMC article.

4

Synthetic lethal screen identification of chemosensitizer loci in cancer cells.

Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, Peyton M, Minna JD, Michnoff C, Hao W, Roth MG, Xie XJ, White MA. Whitehurst AW, et al. Among authors: white ma. Nature. 2007 Apr 12;446(7137):815-9. doi: 10.1038/nature05697. Nature. 2007. PMID: 17429401

5

Ral GTPases and cancer: linchpin support of the tumorigenic platform.

Bodemann BO, White MA. Bodemann BO, et al. Among authors: white ma. Nat Rev Cancer. 2008 Feb;8(2):133-40. doi: 10.1038/nrc2296. Nat Rev Cancer. 2008. PMID: 18219307 Review.

6

RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly.

Bodemann BO, Orvedahl A, Cheng T, Ram RR, Ou YH, Formstecher E, Maiti M, Hazelett CC, Wauson EM, Balakireva M, Camonis JH, Yeaman C, Levine B, White MA. Bodemann BO, et al. Among authors: white ma. Cell. 2011 Jan 21;144(2):253-67. doi: 10.1016/j.cell.2010.12.018. Cell. 2011. PMID: 21241894 Free PMC article.

7

TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation.

Ou YH, Torres M, Ram R, Formstecher E, Roland C, Cheng T, Brekken R, Wurz R, Tasker A, Polverino T, Tan SL, White MA. Ou YH, et al. Among authors: white ma. Mol Cell. 2011 Feb 18;41(4):458-70. doi: 10.1016/j.molcel.2011.01.019. Mol Cell. 2011. PMID: 21329883 Free PMC article.

8

Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.

Kim HS, Mendiratta S, Kim J, Pecot CV, Larsen JE, Zubovych I, Seo BY, Kim J, Eskiocak B, Chung H, McMillan E, Wu S, De Brabander J, Komurov K, Toombs JE, Wei S, Peyton M, Williams N, Gazdar AF, Posner BA, Brekken RA, Sood AK, Deberardinis RJ, Roth MG, Minna JD, White MA. Kim HS, et al. Among authors: white ma. Cell. 2013 Oct 24;155(3):552-66. doi: 10.1016/j.cell.2013.09.041. Epub 2013 Oct 24. Cell. 2013. PMID: 24243015 Free PMC article.

9

RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression.

Ram RR, Mendiratta S, Bodemann BO, Torres MJ, Eskiocak U, White MA. Ram RR, et al. Among authors: white ma. Mol Cell Biol. 2014 Jun;34(12):2350-8. doi: 10.1128/MCB.01506-13. Epub 2014 Apr 14. Mol Cell Biol. 2014. PMID: 24732797 Free PMC article.

10

The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.

Cooper JM, Bodemann BO, White MA. Cooper JM, et al. Among authors: white ma. Enzymes. 2013;34 Pt. B:137-56. doi: 10.1016/B978-0-12-420146-0.00006-8. Epub 2013 Nov 7. Enzymes. 2013. PMID: 25034103 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

701 results

Search Page